SPECIFIC PHARMA A/S: Financial statements 2015
CVR: 33161395
Source: annual report 2015, Danish Business Authority
01/02/2014 – 31/01/2015
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 132,005,000 and a net result of DKK 24,131,000 compared with DKK 18,713,000 the year before. That is a decrease of 4.2% compared with the year before. The profit margin was 18.3%. Equity in the 2015 report amounted to DKK 61,430,000. The solvency ratio was 63.5%. The company had 4 employees in the financial year.
- Revenue
- DKK 132,005,000
- Gross Profit
- DKK 35,944,000
- Profit/Loss
- DKK 24,131,000
- Equity
- DKK 61,430,000
- Total Assets
- DKK 96,800,000
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 132 mio. | 35.9 mio. | 24.1 mio. | 61.4 mio. | 4 |
| 2014 | 137.8 mio. | 30.3 mio. | 18.7 mio. | 37.3 mio. | - |
| 2013 | 60.1 mio. | 16.8 mio. | 10.6 mio. | 18.6 mio. | - |
Official annual report
How creditworthy is SPECIFIC PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The board consists of Kristine Sakstrup Haag (chair), Henrik Kaastrup, Kasper Casparij Yde and Ken Rasmussen. The company is owned by NOMECO A/S. The company has 24 employees (2018). In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity in the 2026 report amounted to DKK 98,645,000.